Blunting of noradrenergic-stimulated growth hormone release in mania

Am J Psychiatry. 1991 Jul;148(7):936-8. doi: 10.1176/ajp.148.7.936.

Abstract

Seven drug-free patients with bipolar affective disorder, currently in a manic phase, underwent desipramine-induced growth hormone (GH) stimulation, as did seven healthy age- and sex-matched subjects. There was significant blunting of GH release in the manic patients, suggesting a down-regulation of alpha 2-noradrenergic responses. Blunting of GH release was not related to severity of symptoms, duration of illness, or age. Similar blunting has previously been described in depressed patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bipolar Disorder / blood
  • Bipolar Disorder / diagnosis*
  • Desipramine* / pharmacology
  • Down-Regulation / drug effects
  • Female
  • Growth Hormone / blood*
  • Humans
  • Male
  • Middle Aged
  • Receptors, Adrenergic, alpha / drug effects

Substances

  • Receptors, Adrenergic, alpha
  • Growth Hormone
  • Desipramine